Physician profile
Aleena Young
NPI 1477241099
$3,092.57
in general payments reported to CMS, 2019-2025
18 companies · $2,113 in 2025
The $2,113 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $132 · 2024: $847 · 2025: $2,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,092.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $472.72 | 2024-2025 | |
| Incyte Corporation | $449.40 | 2024-2025 | Opzelura, Opzelura |
| Arcutis Biotherapeutics, INC. | $303.77 | 2024-2025 | Zoryve |
| Pfizer INC. | $255.06 | 2025 | |
| Leo Pharma INC. | $238.34 | 2024-2025 | Adbry, Anzupgo |
| Organon LLC | $234.57 | 2025 | Vtama |
| Janssen Biotech, INC. | $229.79 | 2023-2025 | Tremfya |
| Galderma Laboratories, L.P. | $158.43 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $153.26 | 2023-2025 | Libtayo, Dupixent |
| Sun Pharmaceutical Industries INC. | $143.41 | 2023-2025 | Blu-U, Odomzo |
| Strata Skin Sciences, INC. | $130.01 | 2023-2025 | Xtrac |
| E.R. Squibb & Sons, L.L.C. | $79.29 | 2024 | Sotyktu |
| Ucb, INC. | $62.80 | 2024 | Bimzelx |
| Amgen INC. | $50.12 | 2024-2025 | Otezla |
| Genzyme Corporation | $43.12 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $32.67 | 2025 | Ebglyss |
| Novartis Pharmaceuticals Corporation | $32.01 | 2025 | |
| Journey Medical Corporation | $23.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleena Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.